Lcz696
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
191 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | HP_0001635 | I50 | 4 | 18 | 18 | 42 | 41 | 119 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 14 | 13 | 6 | 5 | 37 |
| Essential hypertension | D000075222 | — | I10 | — | 5 | 4 | 1 | 1 | 11 |
| Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | 1 | 4 | 4 | 9 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | 4 | 3 | 1 | 9 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | 4 | 2 | 1 | 8 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 3 | 1 | 1 | 2 | 6 |
| Left ventricular dysfunction | D018487 | — | — | — | 1 | 2 | 1 | 1 | 5 |
| Hypertrophy | D006984 | EFO_0002460 | — | — | 4 | 1 | 1 | — | 5 |
| Systolic murmurs | D054160 | — | R01.1 | — | 1 | 2 | 1 | 1 | 5 |
Show 36 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ventricular remodeling | D020257 | — | — | — | 2 | 2 | — | 3 | 7 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | 3 | 2 | — | — | 4 |
| Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | 3 | 1 | — | — | 3 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 1 | — | 1 | 3 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | 1 | 1 | — | — | 3 |
| Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | 1 | — | 1 | 2 |
| St elevation myocardial infarction | D000072657 | — | — | — | — | 2 | — | — | 2 |
| Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | 1 | 1 | — | 1 | 2 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | 1 | — | — | 1 |
| Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | 1 | — | — | — | 3 |
| Atrial remodeling | D064752 | — | — | — | 1 | — | — | 1 | 2 |
| Covid-19 | D000086382 | — | — | 1 | 1 | — | — | 1 | 2 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 2 | — | — | — | 2 |
| Diastolic heart failure | D054144 | EFO_1000899 | I50.30 | — | 2 | — | — | — | 2 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 2 | — | — | — | 2 |
| Chronic renal insufficiency | D051436 | — | N18 | 2 | 1 | — | — | — | 2 |
| Myositis | D009220 | EFO_0000783 | G72.49 | — | 1 | — | — | — | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | 1 | — | — | — | 1 |
| Insulin resistance | D007333 | HP_0000855 | — | — | 1 | — | — | — | 1 |
Show 13 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
| Papillary thyroid cancer | D000077273 | — | — | 1 | — | — | — | — | 1 |
| Thyroid diseases | D013959 | HP_0000820 | E00-E07 | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
| Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
| Hyperkalemia | D006947 | HP_0002153 | E87.5 | — | — | — | — | 1 | 1 |
| Cardio-renal syndrome | D059347 | — | — | — | — | — | — | 1 | 1 |
| Lymphoma | D008223 | — | C85.9 | — | — | — | — | 1 | 1 |
| Univentricular heart | D000080039 | — | Q20.4 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | — |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use